|CrossRef Text and Data Mining|
|Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.|
|Neoadjuvant Chemotherapy in Patients with Advanced Epithelial Ovarian Cancer.|
|Sun Joo Lee, Jeong Won Lee, Chang Soo Park, Byoung Gie Kim, Je Ho Lee, Duk Soo Bae|
|Obstet Gynecol Sci. 2004;47(4):627-633. Published online April 1, 2004|
The role of neoadjuvant chemotherapy in treating advanced epithelial ovarian cancer
The role of neoadjuvant chemotherapy in patients with advanced (stage IIIC) epithelial ovarian cancer
Is there a role for weekly paclitaxel dosing regimen in patients with advanced epithelial ovarian cancer receiving neoadjuvant chemotherapy?
2750 Does neoadjuvant chemotherapy increase the risk of worst outcomes in advanced epithelial ovarian cancer?
Should neoadjuvant chemotherapy be preferred to an alternative treatment for advanced ovarian cancer: Comparison of neoadjuvant chemotherapy followed by interval debulking surgery and primary debulking surgery in patients with advanced ovarian cancer
Is there a survival benefit associated with intraperitoneal chemotherapy after neoadjuvant chemotherapy for optimally debulked epithelial ovarian cancer patients?
Systemic Induction Chemotherapy for Advanced-Stage Epithelial Ovarian Cancer
Primary debulking surgery and neoadjuvant chemotherapy in the treatment of advanced epithelial ovarian carcinoma
Efficacy Evaluation Of Albumin-Bound Paclitaxel Combined With Carboplatin As Neoadjuvant Chemotherapy For Primary Epithelial Ovarian Cancer
Neoadjuvant chemotherapy and interval debulking for advanced epithelial ovarian cancer